# Intrathoracic Rhabdoid Tumor: A Rare Site in a Jordanian Infant

**Authors:** Maher Khader, Ruba Alhazaimeh, Mais Jazazi, Sura Alrawabdeh, Ayat Alalwan, Yara Alkafawin, Ayman Alhwayan, Waseem Almefleh, Hanadi Alkhalaileh, Haneen Alrawashdeh

PMC · DOI: 10.7759/cureus.80520 · Cureus · 2025-03-13

## TL;DR

A rare and aggressive intrathoracic rhabdoid tumor in a Jordanian infant was misdiagnosed initially as a germ cell tumor, highlighting the challenges in diagnosing and treating such tumors in infants.

## Contribution

This case report adds to the limited literature on intrathoracic rhabdoid tumors in infants and emphasizes the diagnostic difficulties in distinguishing them from germ cell tumors.

## Key findings

- The infant was initially misdiagnosed with a germ cell tumor based on immunohistochemical markers.
- A repeat biopsy confirmed the diagnosis of intrathoracic rhabdoid tumor after the patient showed resistance to chemotherapy.
- The tumor metastasized to the liver five months after diagnosis, leading to palliative care.

## Abstract

Intrathoracic rhabdoid tumors in infants are rare and aggressive malignancies that pose significant diagnostic and therapeutic challenges. We report the case of a previously healthy six-month-old full-term infant admitted with severe respiratory distress and desaturation, requiring admission to the pediatric intensive care unit (PICU) and intubation. Initial evaluation suggested left upper lobe pneumonia, but the patient demonstrated minimal improvement with antibiotics and corticosteroids. Then a chest CT was done and revealed a large, heterogeneously enhancing pleural-based mass compressing the left lung, initially interpreted as an aggressive pleural tumor, such as bronchopleural blastoma. The findings led to the urgent initiation of chemotherapy, resulting in temporary clinical improvement that allowed for extubation and a biopsy to be taken. The initial biopsy indicated a germ cell tumor with yolk sac based on these immunohistochemical markers: SALL-4, cytokeratin, and vimentin. However, the patient's lack of a sustained response to chemotherapy and subsequent clinical deterioration prompted a repeat biopsy, which confirmed the diagnosis of an intrathoracic rhabdoid tumor. Despite aggressive multimodal therapy, the patient developed liver metastases five months after the initial diagnosis and was transitioned to palliative care. This case highlights the tumor's complex behavior and resistance to therapy, and underscores the diagnostic challenges associated with intrathoracic masses in infants, particularly the overlap between germ cell tumors and rhabdoid tumors.

## Linked entities

- **Proteins:** SALL4 (spalt like transcription factor 4), krt12.4.S (Keratin 12, gene 4 S homeolog), PRELID1 (PRELI domain containing 1)
- **Diseases:** pneumonia (MONDO:0005249)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** SALL4 (spalt like transcription factor 4) [NCBI Gene 57167] {aka DRRS, HSAL4, IVIC, ZNF797}, VIM (vimentin) [NCBI Gene 7431]
- **Diseases:** respiratory distress (MESH:D012128), malignancies (MESH:D009369), germ cell tumor (MESH:D009373), left upper lobe pneumonia (MESH:D011014), liver (MESH:D017093), metastases (MESH:D009362), bronchopleural blastoma (MESH:D018202), pleural tumor (MESH:D010997), Intrathoracic Rhabdoid Tumor (MESH:D018335)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11993268/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11993268/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC11993268/full.md

---
Source: https://tomesphere.com/paper/PMC11993268